November Private Market UpdatePrivate market metrics show signs of optimism despite October public market slump
November Private Market Update
Trading
Data
Solutions
Insights
About
Artera was founded in 2021 by Andre Esteva. The company has not publicly endorsed plans to participate in an IPO.
Artera is the developer of AI-powered predictive and prognostic cancer tests. The company's flagship product, the ArteraAI Prostate test, aims to predict the benefits of therapy for patients with localized prostate cancer. As of the public launch in March 2023, Artera had raised $90 million in venture capital funding from investors including Coatue, Johnson & Johnson Innovation, Koch Disruptive Technologies, Walden Catalyst Ventures, TIME Ventures, Breyer Capital, and Marc Benioff. Artera did not disclose valuation figures at the time of launch.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
ArteraAI does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for ArteraAI will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 4/25/2022 | Series Seed-1, Seed-2 and Seed-3 | $89.5MM raised | $XXX.XX | $XXX.XX |
ArteraAI is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own ArteraAI pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
ArteraAI is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
